Frequently Asked Questions

The site covers cosmetic peptide raw materials, lyophilized peptide powders, research materials, qualified pharmaceutical-development projects, peptide intermediates, protected amino acids, resins, coupling reagents and selected delivery-format projects. Availability is confirmed for the exact identity and intended use.

Provide the professional name plus CAS, sequence, salt or counter-ion, terminal form and modification where applicable. These details prevent different chemical forms from being treated as the same product.

No. Catalog content supports discovery. The signed quotation, agreed specification, approved sample where applicable and batch COA define the supplied item.

Purity depends on the peptide, form, scale, intended use and analytical method. State the required threshold and method context so the team can confirm a suitable option.

Depending on the item and project, documents may include a specification, batch COA, TDS, SDS, chromatogram, mass data or other agreed records. Not every document applies to every product.

A COA reports applicable batch results, a TDS summarizes technical information, and an SDS communicates hazard and safe-handling information. They serve different purposes.

Yes. Scope may include formula feasibility, lyophilized presentation, kit or dosage-format coordination, sampling, specification, packaging, artwork handoff, production and export.

MOQ may be driven by synthesis or formula batch size, filling setup, vial and closure quantities, custom printing, tooling, assembly or testing. Share sample, pilot and forecast commercial quantities separately.

Timing depends on product identity, development scope, sampling, test plan, component availability, artwork approval, quantity and export requirements. A useful schedule follows a complete brief and feasibility review.

Yes. State the exact product or project, intended use, quantity, destination and evaluation goal so the sample route is relevant to the planned commercial supply.

Follow the label and product-specific technical documents. Temperature, moisture, light, oxygen, closure and post-reconstitution state can differ by product.

No. It can support a suitable formulation, but stability must be demonstrated for the exact composition, process, container and storage conditions.

Yes, subject to exact identity, customer qualification, intended use, project stage, destination, specification, documentation and regulatory review. A public listing is not a consumer medical or dosing offer.

No. Product format and permitted use are confirmed only after qualification and project review. The website does not provide injection or treatment instructions.

Projects may include lyophilized powder kits, dissolvable microneedle patches, dissolvable oral films and other cosmetic delivery concepts, subject to technical feasibility and destination-market review.

Send the product or CAS, intended use, chemical form, purity, quantity, destination, packaging, required documents and target timing. For OEM/ODM, include formula and artwork status.

Use one requirement sheet and compare exact identity, specification, analytical evidence, sample relevance, manufacturing scope, quality-system evidence, documentation, change control and commercial terms.

No. ISO 9001 concerns the quality management system. Product acceptance still depends on the applicable specification, testing and batch documentation.

Not automatically. Finished-product claims require appropriate substantiation and destination-market review for the complete formula, presentation and intended use.

Use the contact form, email info@hytanbio.com or WhatsApp +852 6240 8962. Include your company, project scope and destination for a relevant response.